Osteoporosis screening and treatment in Canada has largely been governed by the 2010 Osteoporosis Canada Guidelines. Now, almost suddenly, we have had a triple threat of recommendations. In 2022, the Society of Obstetricians and Gynaecologists of Canada released guidelines on osteoporosis in menopause. In early 2023, the Canadian Task Force… Read More
This session will use a primary care case-based approach to discuss common inherited cardiac conditions including familial hypercholesterolemia (FH), hypertrophic cardiomyopathy (HCM) and hereditary thoracic aortic aneurysms (HTAA). Often presenting first in primary care, early identification, surveillance, genetics referral when appropriate, and facilitation of familial genetic testing are essential for… Read More
Dans cette séance, on adoptera une approche par cas en soins primaires pour aborder les troubles cardiaques héréditaires courants, dont l’hypercholestérolémie familiale (HF), la cardiomyopathie hypertrophique (CMH) et les anévrismes héréditaires de l’aorte thoracique (AHAT), des affections qui, souvent, se manifestent d’abord dans le contexte des soins primaires. La détection… Read More
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting reproductive-aged women, impacting the lifespan from adolescence to post-menopause. As physicians, we need to acknowledge its complexity as a multifaceted chronic disorder associated with obstetrical, cardiovascular, metabolic, psychological and neoplastic risks, and educate our patients appropriately. While the Rotterdam criteria… Read More
According to Canadian Cancer Society data, breast cancer is the number one cancer diagnosis accounting for 25% of cancers diagnosed in Canada. The lifetime probability of developing breast cancer is 12.1% in persons identified female at birth. 16.3% of breast cancers are diagnosed in cis-gender women between the age of… Read More
